BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35893683)

  • 1. Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two Viruses.
    Liu CY; Guo H; Zhao HZ; Hou LN; Wen YJ; Wang FX
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
    Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
    PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
    Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
    Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic Cell Targeting of Bovine Viral Diarrhea Virus E2 Protein Expressed by
    Wang Y; Feng B; Niu C; Jia S; Sun C; Wang Z; Jiang Y; Cui W; Wang L; Xu Y
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiepitope fusion antigen elicits neutralizing antibodies against enterotoxigenic Escherichia coli and homologous bovine viral diarrhea virus in vitro.
    Hashish EA; Zhang C; Ruan X; Knudsen DE; Chase CC; Isaacson RE; Zhou G; Zhang W
    Clin Vaccine Immunol; 2013 Jul; 20(7):1076-83. PubMed ID: 23697572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
    Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
    BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vaccination of pregnant beef heifers on the concentrations of serum IgG and specific antibodies to bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 in heifers and calves.
    Reppert EJ; Chamorro MF; Robinson L; Cernicchiaro N; Wick J; Weaber RL; Haines DM
    Can J Vet Res; 2019 Oct; 83(4):313-316. PubMed ID: 31571732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant.
    Jia S; Huang X; Li H; Zheng D; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu Y
    Microb Cell Fact; 2020 Oct; 19(1):186. PubMed ID: 33004035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BoHV-1-Vectored BVDV-2 Subunit Vaccine Induces BVDV Cross-Reactive Cellular Immune Responses and Protects against BVDV-2 Challenge.
    Chowdhury SI; Pannhorst K; Sangewar N; Pavulraj S; Wen X; Stout RW; Mwangi W; Paulsen DB
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33451136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus detection by PCR following vaccination of naive calves with intranasal or injectable multivalent modified-live viral vaccines.
    Walz PH; Newcomer BW; Riddell KP; Scruggs DW; Cortese VS
    J Vet Diagn Invest; 2017 Sep; 29(5):628-635. PubMed ID: 28545321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of reproductive performance of primiparous dairy cattle following revaccination with either modified-live or killed multivalent viral vaccines in early lactation.
    Walz PH; Montgomery T; Passler T; Riddell KP; Braden TD; Zhang Y; Galik PK; Zuidhof S
    J Dairy Sci; 2015 Dec; 98(12):8753-63. PubMed ID: 26454300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge.
    Liang R; van den Hurk JV; Landi A; Lawman Z; Deregt D; Townsend H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2008 Feb; 89(Pt 2):453-466. PubMed ID: 18198376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mosaic Bovine Viral Diarrhea Virus Antigens Elicit Cross-Protective Immunity in Calves.
    Sangewar N; Hassan W; Lokhandwala S; Bray J; Reith R; Markland M; Sang H; Yao J; Fritz B; Waghela SD; Abdelsalam KW; Chase CCL; Mwangi W
    Front Immunol; 2020; 11():589537. PubMed ID: 33281819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel bovine viral diarrhea virus (BVDV) virus-like particle vaccine candidates presenting the E2 protein using the SpyTag/SpyCatcher system induce a robust neutralizing antibody response in mice.
    Katsura M; Fukushima M; Kameyama KI; Kokuho T; Nakahira Y; Takeuchi K
    Arch Virol; 2023 Jan; 168(2):49. PubMed ID: 36609880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.